抗载脂蛋白A-1自身抗体与系统性红斑狼疮疾病活动度相关
该研究在瑞士SLE队列中检测176名个体的354份生物样本,评估抗ApoA-1 IgG及抗F3L1 IgG的临床性能。结果显示抗ApoA-1和抗F3L1 IgG阳性与较高SLEDAI相关,主要因dsDNA IgG阳性及低补体;抗ApoA-1 IgG随时间变化与抗dsDNA IgG变化正相关、与C3水平变化负相关,但与心血管事件无显著关联。
要点
- 抗ApoA-1和抗F3L1 IgG阳性与较高SLEDAI相关,主要归因于dsDNA IgG阳性和低补体。
- 抗ApoA-1 IgG随时间变化与抗dsDNA IgG变化正相关,与C3水平变化负相关。
- 抗ApoA-1 IgG阳性与心血管事件无显著关联,其在CVEs中的作用需进一步研究。
核心结论
- SLE中抗ApoA-1和抗F3L1 IgG与实验室活动度标志物强烈相关,尤其与dsDNA IgG的存在和滴度相关。
研究设计与样本
- 研究纳入176名个体的354份生物样本和访谈,记录SLEDAI、临床特征、既往心血管事件及治疗详情。
- 检测血清中抗ApoA-1 IgG、抗F3L1 IgG、抗dsDNA IgG和aPL的存在。
主要发现
- 抗ApoA-1和抗F3L1 IgG阳性与较高SLEDAI相关,主要因同时存在dsDNA IgG阳性和低补体。
- 抗ApoA-1 IgG随时间的变化与抗dsDNA IgG变化正相关,与C3水平变化负相关。
- 抗ApoA-1与抗dsDNA IgG之间未发现交叉反应。
- 接受泼尼松≥10 mg/天的个体中抗ApoA-1 IgG阳性更常见。
- 抗ApoA-1 IgG阳性与心血管事件无显著关联。
临床怎么用
- 抗ApoA-1 IgG可用于SLE临床评估,因其与dsDNA IgG等实验室活动度标志物强相关。
局限性
- 抗ApoA-1 IgG在心血管事件中的作用尚需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Apolipoprotein A-1 (ApoA-1) is a protein fraction of the high-density lipoproteins with anti-inflammatory and antioxidant properties that play a major role in reverse cholesterol transport. The presence of anti-ApoA-1 IgG has been reported in SLE to be variably associated with disease activity or cardiovascular events (CVEs). We assessed the clinical performance of anti-ApoA-1 IgG and of antibodies directed against its immunodominant F3L1 peptide (F3L1 IgG) in a well-characterized Swiss SLE cohort study. METHODS: A total of 354 biological samples and interviews from 176 individuals were studied. SLEDAI, clinical characteristics, anamnestic CVEs and therapy details were recorded. Sera were tested for the presence of anti-ApoA-1 IgG, anti-F3L1 IgG, anti-dsDNA IgG and aPL. RESULTS: Anti-ApoA-1 and anti-F3L1 IgG positivity was associated with higher SLEDAI, mostly due to concomitant positivity of dsDNA IgG and low complement. Variations in time of anti-ApoA-1 IgG correlated positively with variations of anti-dsDNA IgG and inversely to variations of C3 levels. No cross-reactivity was found between anti-ApoA-1 and anti-dsDNA IgG. Positivity for anti-Apo-A1 IgG was more frequent in individuals receiving 10 mg/day or more of prednisone. We did not find any significant association between anti-ApoA-1 IgG positivity and CVEs. CONCLUSION: Anti-ApoA-1 and anti-F3L1 IgG in SLE correlate strongly with laboratory markers of activity, particularly with the presence and titre of dsDNA IgG. These results confirm and extend previous findings and support the use of anti-ApoA1 IgG in the clinical setting. Their role in CVEs deserves further investigation.
引用
- Nigolian H, Ribi C, Courvoisier DS, et al. Anti-apolipoprotein A-1 autoantibodies correlate with disease activity in systemic lupus erythematosus. Rheumatology (Oxford). 2020. PMID: 31377780. doi:10.1093/rheumatology/kez306
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。